Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 337 entries
Sorted by: Best Match Show Resources per page
Defining the human: Are transgender people strangers to the law

gender (e.g., male, women, girls, transgender)

Lloyd AW.
GSID: SnpnDkR2JL0J
AW Lloyd - Berkeley J. Gender L. & Just., 2005 - HeinOnline

… of masculine females and feminine males, cross-dressers, … the girls found out that Sean was actually a biological woman … restrictive gender binary (for example, a transgender man may …

Cite
Lloyd, A. W. (2005). Defining the human: Are transgender people strangers to the law. Berkeley J. Gender L. & Just., 20, 150.
Lloyd, Abigail W. "Defining the human: Are transgender people strangers to the law." Berkeley J. Gender L. & Just. 20 (2005): 150.
Copy Download .nbib Format: MLA
Associations between common mental disorders and the Mental Illness Needs Index in community settings: Multilevel analysis

community settings

Lloyd K.
GSID: GClqT51Kw8AJ
DL Fone, F Dunstan, A John, K Lloyd - The British Journal of …, 2007 - cambridge.org

… disorder in community settings. … settings in the same way that it is used for severe mental illness in secondary care settings. Scores calculated for general practice populations will be useful to primary care organisations in understanding the...

Cite
Fone, D. L., Dunstan, F., John, A., & Lloyd, K. (2007). Associations between common mental disorders and the Mental Illness Needs Index in community settings: Multilevel analysis. The British Journal of Psychiatry, 191(2), 158-163.
Fone, David L., et al. "Associations between common mental disorders and the Mental Illness Needs Index in community settings: Multilevel analysis." The British Journal of Psychiatry 191.2 (2007): 158-163.
Copy Download .nbib Format: MLA
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative.

Open forum infectious diseases

Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH.
PMID: 26973850
Open Forum Infect Dis. 2016 Feb 08;3(1):ofw024. doi: 10.1093/ofid/ofw024. eCollection 2016 Jan.

Symptomatic acute HCV infection and interferon lambda 4 (IFNL4) genotypes are important predictors of spontaneous viral clearance. Using data from a multicohort database (Injecting Cohorts [InC3] Collaborative), we establish an independent association between host IFNL4 genotype and symptoms of...

Cite
Page K, Mirzazadeh A, Rice TM, et al. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016;3(1):ofw024doi: 10.1093/ofid/ofw024.
Page, K., Mirzazadeh, A., Rice, T. M., Grebely, J., Kim, A. Y., Cox, A. L., Morris, M. D., Hellard, M., Bruneau, J., Shoukry, N. H., Dore, G. J., Maher, L., Lloyd, A. R., Lauer, G., Prins, M., & McGovern, B. H. (2016). Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open forum infectious diseases, 3(1), ofw024. https://doi.org/10.1093/ofid/ofw024
Page, Kimberly, et al. "Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative." Open forum infectious diseases vol. 3,1 (2016): ofw024. doi: https://doi.org/10.1093/ofid/ofw024
Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Feb 08;3(1):ofw024. doi: 10.1093/ofid/ofw024. eCollection 2016 Jan. PMID: 26973850; PMCID: PMC4785397.
Copy Download .nbib Format: NLM
Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening.

International journal of genomics

Gurumurthy CB, Joshi PS, Kurz SG, Ohtsuka M, Quadros RM, Harms DW, Lloyd KC.
PMID: 25815306
Int J Genomics. 2015;2015:735845. doi: 10.1155/2015/735845. Epub 2015 Feb 28.

Marker assisted speed congenics technique is commonly used to facilitate backcrossing of mouse strains in nearly half the time it normally takes otherwise. Traditionally, the technique is performed by analyzing PCR amplified regions of simple sequence length polymorphism (SSLP)...

Cite
Gurumurthy CB, Joshi PS, Kurz SG, et al. Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening. Int J Genomics. 2015;2015:735845doi: 10.1155/2015/735845.
Gurumurthy, C. B., Joshi, P. S., Kurz, S. G., Ohtsuka, M., Quadros, R. M., Harms, D. W., & Lloyd, K. C. (2015). Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening. International journal of genomics, 2015735845. https://doi.org/10.1155/2015/735845
Gurumurthy, Channabasavaiah B, et al. "Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening." International journal of genomics vol. 2015 (2015): 735845. doi: https://doi.org/10.1155/2015/735845
Gurumurthy CB, Joshi PS, Kurz SG, Ohtsuka M, Quadros RM, Harms DW, Lloyd KC. Validation of simple sequence length polymorphism regions of commonly used mouse strains for marker assisted speed congenics screening. Int J Genomics. 2015;2015:735845. doi: 10.1155/2015/735845. Epub 2015 Feb 28. PMID: 25815306; PMCID: PMC4359823.
Copy Download .nbib Format: NLM
Health State Utilities In Chronic Heart Failure In The Uk.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Nafees B, Cowie MR, Patel C, Deschaseaux C, Brazier J, Lloyd AJ.
PMID: 27201470
Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1462. Epub 2014 Oct 26.

No abstract available.

Cite
Nafees B, Cowie MR, Patel C, et al. Health State Utilities In Chronic Heart Failure In The Uk. Value Health. 2014;17(7):A493doi: 10.1016/j.jval.2014.08.1462.
Nafees, B., Cowie, M. R., Patel, C., Deschaseaux, C., Brazier, J., & Lloyd, A. J. (2014). Health State Utilities In Chronic Heart Failure In The Uk. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A493. https://doi.org/10.1016/j.jval.2014.08.1462
Nafees, B, et al. "Health State Utilities In Chronic Heart Failure In The Uk." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A493. doi: https://doi.org/10.1016/j.jval.2014.08.1462
Nafees B, Cowie MR, Patel C, Deschaseaux C, Brazier J, Lloyd AJ. Health State Utilities In Chronic Heart Failure In The Uk. Value Health. 2014 Nov;17(7):A493. doi: 10.1016/j.jval.2014.08.1462. Epub 2014 Oct 26. PMID: 27201470.
Copy Download .nbib Format: NLM
What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?.

Patient preference and adherence

Lloyd AJ, Nafees B, Ziani E, Nicolas L, Fordham BA, Soubeyrand B, Bornhöft C.
PMID: 26604704
Patient Prefer Adherence. 2015 Oct 27;9:1517-24. doi: 10.2147/PPA.S87229. eCollection 2015.

Diphtheria, tetanus and acellular pertussis (DTaP) based combined vaccines have led to significant reduction in incidence of several serious pediatric infectious diseases. A new, fully liquid combined hexavalent vaccine has been introduced and has been shown to reduce administration...

Cite
Lloyd AJ, Nafees B, Ziani E, et al. What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?. Patient Prefer Adherence. 2015;9:1517-24doi: 10.2147/PPA.S87229.
Lloyd, A. J., Nafees, B., Ziani, E., Nicolas, L., Fordham, B. A., Soubeyrand, B., & Bornhöft, C. (2015). What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?. Patient preference and adherence, 91517-24. https://doi.org/10.2147/PPA.S87229
Lloyd, Andrew J, et al. "What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?." Patient preference and adherence vol. 9 (2015): 1517-24. doi: https://doi.org/10.2147/PPA.S87229
Lloyd AJ, Nafees B, Ziani E, Nicolas L, Fordham BA, Soubeyrand B, Bornhöft C. What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution?. Patient Prefer Adherence. 2015 Oct 27;9:1517-24. doi: 10.2147/PPA.S87229. eCollection 2015. PMID: 26604704; PMCID: PMC4630204.
Copy Download .nbib Format: NLM
[No title available]

The International journal on drug policy

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ.
PMID: 26749563
Int J Drug Policy. 2015 Nov 28; doi: 10.1016/j.drugpo.2015.11.010. Epub 2015 Nov 28.

No abstract available.

Cite
Grebely J, Robaeys G, Bruggmann P, et al. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. . Int J Drug Policy. 2015;doi: 10.1016/j.drugpo.2015.11.010.
Grebely, J., Robaeys, G., Bruggmann, P., Aghemo, A., Backmund, M., Bruneau, J., Byrne, J., Dalgard, O., Feld, J. J., Hellard, M., Hickman, M., Kautz, A., Litwin, A., Lloyd, A. R., Mauss, S., Prins, M., Swan, T., Schaefer, M., Taylor, L. E., Dore, G. J. (2015). Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. . The International journal on drug policy, . https://doi.org/10.1016/j.drugpo.2015.11.010
Grebely, Jason, et al. "Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden." . The International journal on drug policy vol. (2015). doi: https://doi.org/10.1016/j.drugpo.2015.11.010
Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden. . Int J Drug Policy. 2015 Nov 28; doi: 10.1016/j.drugpo.2015.11.010. Epub 2015 Nov 28. German. PMID: 26749563.
Copy Download .nbib Format: NLM
Monitor: progress and profiles.

Pharmaceutical science & technology today

Lloyd AW, Hunter AC.
PMID: 10407393
Pharm Sci Technol Today. 1999 Jul;2(7):299-302. doi: 10.1016/s1461-5347(99)00169-8.

No abstract available.

Cite
Lloyd AW, Hunter AC. Monitor: progress and profiles. Pharm Sci Technol Today. 1999;2(7):299-302doi: 10.1016/s1461-5347(99)00169-8.
Lloyd, A. W., & Hunter, A. C. (1999). Monitor: progress and profiles. Pharmaceutical science & technology today, 2(7), 299-302. https://doi.org/10.1016/s1461-5347(99)00169-8
Lloyd, and Hunter. "Monitor: progress and profiles." Pharmaceutical science & technology today vol. 2,7 (1999): 299-302. doi: https://doi.org/10.1016/s1461-5347(99)00169-8
Lloyd AW, Hunter AC. Monitor: progress and profiles. Pharm Sci Technol Today. 1999 Jul;2(7):299-302. doi: 10.1016/s1461-5347(99)00169-8. PMID: 10407393.
Copy Download .nbib Format: NLM
Monitor: progress and profiles.

Pharmaceutical science & technology today

Lloyd AW, Hunter AC.
PMID: 10637600
Pharm Sci Technol Today. 2000 Jan;3(1):42-45. doi: 10.1016/s1461-5347(99)00234-5.

Monitor provides an insight into the latest developments in pharmaceutical science and technology through brief synopses of recent presentations, publications and patents, and expert commentaries on the latest technologies. There are two sections: Progress summarizes the latest developments in...

Cite
Lloyd AW, Hunter AC. Monitor: progress and profiles. Pharm Sci Technol Today. 2000;3(1):42-45doi: 10.1016/s1461-5347(99)00234-5.
Lloyd, A. W., & Hunter, A. C. (2000). Monitor: progress and profiles. Pharmaceutical science & technology today, 3(1), 42-45. https://doi.org/10.1016/s1461-5347(99)00234-5
Lloyd, and Hunter. "Monitor: progress and profiles." Pharmaceutical science & technology today vol. 3,1 (2000): 42-45. doi: https://doi.org/10.1016/s1461-5347(99)00234-5
Lloyd AW, Hunter AC. Monitor: progress and profiles. Pharm Sci Technol Today. 2000 Jan;3(1):42-45. doi: 10.1016/s1461-5347(99)00234-5. PMID: 10637600.
Copy Download .nbib Format: NLM
Monitor: molecules and profiles.

Drug discovery today

Lloyd AW.
PMID: 10529770
Drug Discov Today. 1999 Nov;4(11):530-531. doi: 10.1016/s1359-6446(99)01410-5.

Monitor provides an insight into the latest developments in drug discovery through brief synopses of recent presentations and publications together with expert commentaries on the latest technologies. There are two sections: Molecules summarizes the chemistry and the pharmacological significance...

Cite
Lloyd AW. Monitor: molecules and profiles. Drug Discov Today. 1999;4(11):530-531doi: 10.1016/s1359-6446(99)01410-5.
Lloyd, A. W. (1999). Monitor: molecules and profiles. Drug discovery today, 4(11), 530-531. https://doi.org/10.1016/s1359-6446(99)01410-5
Lloyd. "Monitor: molecules and profiles." Drug discovery today vol. 4,11 (1999): 530-531. doi: https://doi.org/10.1016/s1359-6446(99)01410-5
Lloyd AW. Monitor: molecules and profiles. Drug Discov Today. 1999 Nov;4(11):530-531. doi: 10.1016/s1359-6446(99)01410-5. PMID: 10529770.
Copy Download .nbib Format: NLM
Monitor: progress and profiles.

Pharmaceutical science & technology today

Lloyd AW.
PMID: 10234210
Pharm Sci Technol Today. 1999 Feb;2(2):83-86. doi: 10.1016/s1461-5347(99)00124-8.

Monitor provides an insight into the latest developments in pharmaceutical science and technology through brief synopses of recent presentations, publications and patents, and expert commentaries on the latest technologies. There are two sections: Progress summarizes the latest developments in...

Cite
Lloyd AW. Monitor: progress and profiles. Pharm Sci Technol Today. 1999;2(2):83-86doi: 10.1016/s1461-5347(99)00124-8.
Lloyd, A. W. (1999). Monitor: progress and profiles. Pharmaceutical science & technology today, 2(2), 83-86. https://doi.org/10.1016/s1461-5347(99)00124-8
Lloyd. "Monitor: progress and profiles." Pharmaceutical science & technology today vol. 2,2 (1999): 83-86. doi: https://doi.org/10.1016/s1461-5347(99)00124-8
Lloyd AW. Monitor: progress and profiles. Pharm Sci Technol Today. 1999 Feb;2(2):83-86. doi: 10.1016/s1461-5347(99)00124-8. PMID: 10234210.
Copy Download .nbib Format: NLM
Toward a rapid, integrated, and fully automated DNA diagnostic assay for chlamydia trachomatis and neisseria gonorrhoeae.

Clinical chemistry

Pourahmadi F, Taylor M, Kovacs G, Lloyd K, Sakai S, Schafer T, Helton B, Western L, Zaner S, Ching J, McMillan B, Belgrader P, Northrup MA.
PMID: 10973906
Clin Chem. 2000 Sep;46(9):1511-3.

No abstract available.

Cite
Pourahmadi F, Taylor M, Kovacs G, et al. Toward a rapid, integrated, and fully automated DNA diagnostic assay for chlamydia trachomatis and neisseria gonorrhoeae. Clin Chem. 2000;46(9):1511-3
Pourahmadi, F., Taylor, M., Kovacs, G., Lloyd, K., Sakai, S., Schafer, T., Helton, B., Western, L., Zaner, S., Ching, J., McMillan, B., Belgrader, P., & Northrup, M. A. (2000). Toward a rapid, integrated, and fully automated DNA diagnostic assay for chlamydia trachomatis and neisseria gonorrhoeae. Clinical chemistry, 46(9), 1511-3.
Pourahmadi, et al. "Toward a rapid, integrated, and fully automated DNA diagnostic assay for chlamydia trachomatis and neisseria gonorrhoeae." Clinical chemistry vol. 46,9 (2000): 1511-3.
Pourahmadi F, Taylor M, Kovacs G, Lloyd K, Sakai S, Schafer T, Helton B, Western L, Zaner S, Ching J, McMillan B, Belgrader P, Northrup MA. Toward a rapid, integrated, and fully automated DNA diagnostic assay for chlamydia trachomatis and neisseria gonorrhoeae. Clin Chem. 2000 Sep;46(9):1511-3. PMID: 10973906.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 337 entries